Suppr超能文献

小分子诱导的 STING 降解由 HECT 连接酶 HERC4 介导。

Small molecule induced STING degradation facilitated by the HECT ligase HERC4.

机构信息

Novartis BioMedical Research, Basel, Switzerland.

Amsterdam UMC location Vrije Universiteit Amsterdam, Molecular Cell Biology & Immunology, Amsterdam institute for Infection and Immunity, De Boelelaan, 1117, Amsterdam, The Netherlands.

出版信息

Nat Commun. 2024 May 29;15(1):4584. doi: 10.1038/s41467-024-48922-w.

Abstract

Stimulator of interferon genes (STING) is a central component of the cytosolic nucleic acids sensing pathway and as such master regulator of the type I interferon response. Due to its critical role in physiology and its' involvement in a variety of diseases, STING has been a focus for drug discovery. Targeted protein degradation (TPD) has emerged as a promising pharmacology for targeting previously considered undruggable proteins by hijacking the cellular ubiquitin proteasome system (UPS) with small molecules. Here, we identify AK59 as a STING degrader leveraging HERC4, a HECT-domain E3 ligase. Additionally, our data reveals that AK59 is effective on the common pathological STING mutations, suggesting a potential clinical application of this mechanism. Thus, these findings introduce HERC4 to the fields of TPD and of compound-induced degradation of STING, suggesting potential therapeutic applications.

摘要

干扰素基因刺激物 (STING) 是细胞质核酸感应途径的核心组成部分,也是 I 型干扰素反应的主要调节剂。由于其在生理学中的关键作用及其在多种疾病中的参与,STING 一直是药物发现的重点。靶向蛋白降解 (TPD) 已成为一种有前途的药理学方法,通过利用小分子劫持细胞内泛素蛋白酶体系统 (UPS) 来靶向以前被认为不可成药的蛋白质。在这里,我们确定 AK59 是一种利用 HECT 结构域 E3 连接酶 HERC4 的 STING 降解剂。此外,我们的数据表明 AK59 对常见的病理性 STING 突变有效,这表明该机制具有潜在的临床应用。因此,这些发现将 HERC4 引入 TPD 领域和化合物诱导的 STING 降解领域,表明具有潜在的治疗应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c51f/11137104/777295ad24f2/41467_2024_48922_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验